Page 3 of 6
Which participants took part in this study?
Studies have a list of requirements for participants who can enrol (inclusion criteria)
and those who can’t (exclusion criteria). For this study, the main inclusion and
exclusion criteria are listed below.
Men and women with chronic hepatitis B were included in the study if they:
• Were 18 to 60 years old.
• Had presence of HBsAg protein in blood at the start of the study and for
at least six months before starting the study.
• Had the required HBV DNA levels based on the presence or absence of
HBeAg in the blood at the start of the study.
Men and women were excluded from the study if they had:
• A liver transplant or planned to have one.
• Cancer or signs of disease in the liver.
• An infection with HIV or any of the other hepatitis virus (A, C, D, or E).
• More than ten times the normal levels of a liver protein in the blood
(alanine aminotransferase) before starting the study.
• Alcohol or drug problem currently or in the past.
• Received TDF or similar medicines before starting the study.
• Any other disease(s), abnormal blood test results, or taken any
treatment(s) that the study doctor thought would affect the results of
the study.
Overall, 195 participants received at least one dose of the study medicine. The study
included 148 men (76%) and 47 women (24%). The average age was 42 years. The
youngest participant was 21 years old and the oldest participant was 60 years old.
For more detailed information about the participants included in this study, see the
scientific results summary (a link to the summary is provided at the end of this
document).